Friday, July 31, 2026

Kolon Group’s Biotech Bet Faces Uncertainty as October Trial Readout Becomes Critical

Kolon TissueGene's TG-C osteoarthritis treatment failed its first U.S. Phase 3 trial, raising doubts about the biotech's future.

Wontech to host ‘Wave Tokyo’ in Japan, officially launch SANDRO Dual

Wontech will host "Wave Tokyo" on April 26 to launch SANDRO Dual, expanding its presence in Asia after "Wave Beijing."

Golfing on Duty: Presidential Guard Commander Under Scrutiny

The commanding officer protecting the president and...

Tag: infectious diseases

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

WHO Warns of Next Pandemic as Infectious Disease Preparedness Remains Critical; SK Bioscience Draws Attention

SK Bioscience enhances South Korea's pandemic preparedness with vaccine innovations and global partnerships, focusing on future growth.

How Hyundai BioScience’s XAFTY Could Revolutionize Ebola Treatment: A Free Supply Proposal

Hyundai Bio USA proposes to provide antiviral candidate XAFTY for free to Ebola-affected countries, aiming to combat the disease urgently.

How International Collaboration is Revolutionizing Infectious Disease Research in Asia

Korea's Disease Control Agency establishes a framework for local medical institutions to join international clinical trials for infectious diseases.

The 2026 World Cup Could Bring More Than Soccer Fever, Korean Officials Warn

South Korean health authorities issue guidelines for infectious disease prevention for athletes and travelers at the 2026 FIFA World Cup.

How the Late Lee Kun-hee’s 700 Billion Won Donation is Transforming Infectious Disease Research in Korea

The KDCA will host two international symposia on infectious disease research to enhance collaboration and response capabilities starting March 26.

1 Trillion KRW Donation: How the Lee Kun-hee Legacy is Transforming Infectious Disease Research in Korea

Samsung's donation aids childhood cancer and rare diseases, funding research and infrastructure to combat infectious diseases in South Korea.

Hyundai Bioscience Launches Global Clinical Trials for Dengue Treatment in Vietnam

Hyundai BioScience launches global clinical trials for a broad-spectrum antiviral treatment targeting dengue fever in Vietnam.

DDM Immune Prep Delivers 100% Survival Against Drug-Resistant Bacteria and Flu in Pre-Exposure Tests

Researchers develop a novel infection-prevention strategy using DDM, enhancing immune response against antibiotic-resistant pathogens.

Global HIV Infections Set to Hit Record High by 2039, Study Reveals

A study predicts global HIV infections will peak at 444 million by 2039, despite declines in some regions and ongoing treatment advancements.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.